Mycophenolic Acid Displays IMPDH-Dependent and IMPDH-Independent Effects on Renal Fibroblast Proliferation and Function

2010 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Mycophenolic Acid Displays IMPDH-Dependent and IMPDH-Independent Effects on Renal Fibroblast Proliferation and Function​
Petrova, D. T.; Brandhorst, G.; Brehmer, F. ; Gross, O.; Oellerich, M. & Armstrong, V. W.​ (2010) 
Therapeutic Drug Monitoring32(4) pp. 405​-412​.​ DOI: https://doi.org/10.1097/FTD.0b013e3181e44260 

Documents & Media

License

GRO License GRO License

Details

Authors
Petrova, Darinka T.; Brandhorst, Gunnar; Brehmer, Franziska ; Gross, Oliver; Oellerich, Michael; Armstrong, Victor William
Abstract
The aim of this study was to elucidate the role of mycophenolic acid (MPA) in cellular pathways of renal fibrosis. Different assays were applied in a renal fibroblast model using COS-7 cells: assays for cell proliferation, scratch wound closure and collagen matrix contraction, gene quantification, and Western blotting. The results indicate that MPA treatment leads to inosine monophosphate dehydrogenase (IMPDH)-dependent inhibition of fibroblast proliferation and wound closure as well as an unexpected IMPDH-independent inhibition of collagen matrix contraction. Interestingly, the IMPDH-independent expression of CTGF after 6 hours incubation with MPA was significantly decreased; however, it became significantly increased and IMPDH-dependent after 24 hours of incubation and longer. Increased mRNA level of COL1A1, TGF beta 1, and TNF alpha was observed after MPA treatment. An unanticipated finding was the divergent and late MPA effect leading to a significant increase of TGF beta 1 and CTGF gene expression. The results suggest that long-term incubation with MPA alters signals located upstream of transforming growth factor-beta. Furthermore, the protein expression of the apoptotic marker ANXA5 was analyzed in the cell line to exclude apoptosis-related effects using 0.1 to 100 mu mol/L MPA. Moreover, in COL4A3-deficient mice treated with different doses of mycophenolate mofetil, we found no significant differences in the gene expression of the same genes supporting the idea of a TGF beta-independent pathway of tubulointerstitial fibrosis in this model for progressive renal disease. In conclusion, the current study indicates that MPA displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function as well as complex signal transduction in COS-7-cells. Alternative inhibitory pathways may contribute to antifibrotic effect of MPA.
Issue Date
2010
Status
published
Publisher
Lippincott Williams & Wilkins
Journal
Therapeutic Drug Monitoring 
ISSN
0163-4356
Sponsor
Roche Pharma AG, Grenzach-Wyhlen, Germany

Reference

Citations


Social Media